The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Pregabalin Clonmel 300 mg capsules, hard

300 milligram(s) Capsule, hard

Clonmel Healthcare LtdPA0126/290/008

Main Information

Trade NamePregabalin Clonmel 300 mg capsules, hard
Active SubstancesPregabalin
Strength300 milligram(s)
Dosage FormCapsule, hard
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/290/008

Group Information

ATC CodeN03AX Other antiepileptics
N03AX16 pregabalin

Status

Authorised/WithdrawnAuthorised
Licence Issued12/01/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListPregabalin 300mg Capsules
Interchangeable List CodeIC0110-029-001
Interchangeable List DocumentPDF of Interchangeable List
« Back